SOPHiA GENETICS $SOPH

Information Technology

$8.20
+0.13 (+1.61%)
As of Oct 5, 2026, 5:14 PM EDT · cached
Price history
Loading chart…

SOPHiA GENETICS (SOPH) is trading up at $8.20 (+1.61%), as of the latest quote. It operates in the Information Technology sector.

IPO: July 23, 2021 · $18.00 offering · NASDAQ · View IPO details →

SOPHiA GENETICS revenue & net income history (FY2019–FY2025)

RevenueNet income
$77.3M−$5.09M−$87.4MFY2019 revenue: $25.4MFY2019 net income: −$33.8M'19FY2020 revenue: $28.4MFY2020 net income: −$39.3M'20FY2021 revenue: $40.5MFY2021 net income: −$73.7M'21FY2022 revenue: $47.6MFY2022 net income: −$87.4M'22FY2023 revenue: $62.4MFY2023 net income: −$79.0M'23FY2024 revenue: $65.2MFY2024 net income: −$62.5M'24FY2025 revenue: $77.3MFY2025 net income: −$79.0M'25
SOPHiA GENETICS annual financial statements
FY2019Dec 2019FY2020Dec 2020FY2021Dec 2021FY2022Dec 2022FY2023Dec 2023FY2024Dec 2024FY2025Dec 2025
Income statement
Revenue$25.4M$28.4M$40.5M$47.6M$62.4M$65.2M$77.3M
Growth (year over year)—+12.0%+42.4%+17.6%+31.1%+4.5%+18.6%
Gross profit$17.8M$17.7M$25.2M$31.3M$42.9M$43.9M$52.1M
Gross margin70.3%62.3%62.4%65.7%68.8%67.4%67.4%
Operating income—−$37.4M−$71.5M−$87.8M−$74.8M−$66.6M−$70.9M
Operating margin—−131.6%−176.7%−184.7%−120.0%−102.1%−91.8%
Net income−$33.8M−$39.3M−$73.7M−$87.4M−$79.0M−$62.5M−$79.0M
Net margin−133.2%−138.5%−182.1%−183.9%−126.6%−95.9%−102.2%
EPS (diluted)—−$0.93−$1.33−$1.36−$1.22−$0.95−$1.17
Balance sheet
Cash and equivalents$18.1M$74.6M$193.0M$161.3M$123.3M$80.2M$70.3M
Total assets—$132.1M$320.2M$243.8M$206.2M$155.3M$163.0M
Total liabilities—$31.6M$44.8M$43.7M$54.7M$58.8M$115.9M
Shareholders' equity$22.3M$100.5M$275.4M$200.1M$151.4M$96.5M$47.1M
Cash flow
Operating cash flow−$31.7M−$31.7M−$57.9M−$70.1M−$53.2M−$44.5M−$35.9M
Capital expenditure$1.35M$450.0K$2.68M$4.10M$1.49M$244.0K$574.0K
Free cash flow−$33.0M−$32.2M−$60.6M−$74.2M−$54.7M−$44.8M−$36.5M

From SOPHiA GENETICS's 20-F and 6-K filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Per-share figures are per ordinary share, which is not always the share traded in the US: an ADS can stand for several, or for part of one. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

About SOPHiA GENETICS

Sophia Genetics SA is a Swiss-founded data-driven medicine software company with headquarters in Rolle, Switzerland and Boston, Massachusetts, as well as offices in France. It provides genomic and radiomic, and multimodal analysis for hospitals, laboratories, and biopharma institutions.

Source: Wikipedia — Sophia Genetics

Headquarters
Rolle, Switzerland From SEC filings, Oct 2026

Recent News

No recent news mentioning SOPHiA GENETICS in our feed yet.

Other Information Technology companies to compare with SOPH

Browse all companies →